Australia was amongst the first wave of countries to record COVID-19 cases, with the first case in late January. The COVID-19 crisis has had a strongly negative impact on the MTP sector, as it has on many other parts of the Australian economy. Our latest report outlines these impacts and how the sector has responded to the challenges posed by the pandemic.
Life Sciences & Pharma
EUnetHTA 21 — Transition to EU-wide HTAs: Implications for Pharma
L.E.K. Consulting’s Inaugural Clinical and eClinical Pharma Services Survey